Department of Molecular and Cellular Physiology (Y.W.L., N.M., B.D.G., J.M.L., P.A.V., A.P.A., J.J.S.), Albany Medical College, NY.
Department of Ophthalmology (A.P.A.), Albany Medical College, NY.
Arterioscler Thromb Vasc Biol. 2021 Mar;41(3):1105-1123. doi: 10.1161/ATVBAHA.120.314978. Epub 2021 Jan 7.
Atherosclerosis predominantly forms in regions of oscillatory shear stress while regions of laminar shear stress are protected. This protection is partly through the endothelium in laminar flow regions expressing an anti-inflammatory and antithrombotic gene expression program. Several molecular pathways transmitting these distinct flow patterns to the endothelium have been defined. Our objective is to define the role of the MEF2 (myocyte enhancer factor 2) family of transcription factors in promoting an atheroprotective endothelium. Approach and Results: Here, we show through endothelial-specific deletion of the 3 MEF2 factors in the endothelium, Mef2a, -c, and -d, that MEF2 is a critical regulator of vascular homeostasis. MEF2 deficiency results in systemic inflammation, hemorrhage, thrombocytopenia, leukocytosis, and rapid lethality. Transcriptome analysis reveals that MEF2 is required for normal regulation of 3 pathways implicated in determining the flow responsiveness of the endothelium. Specifically, MEF2 is required for expression of Klf2 and Klf4, 2 partially redundant factors essential for promoting an anti-inflammatory and antithrombotic endothelium. This critical requirement results in phenotypic similarities between endothelial-specific deletions of and . In addition, MEF2 regulates the expression of Notch family genes, Notch1, Dll1, and Jag1, which also promote an atheroprotective endothelium. In contrast to these atheroprotective pathways, MEF2 deficiency upregulates an atherosclerosis promoting pathway through increasing the amount of TAZ (transcriptional coactivator with PDZ-binding motif).
Our results implicate MEF2 as a critical upstream regulator of several transcription factors responsible for gene expression programs that affect development of atherosclerosis and promote an anti-inflammatory and antithrombotic endothelium. Graphic Abstract: A graphic abstract is available for this article.
动脉粥样硬化主要在振荡剪切应力区域形成,而层流剪切应力区域则受到保护。这种保护部分是通过层流区域内皮表达抗炎和抗血栓基因表达程序来实现的。已经定义了几个将这些不同的流动模式传递到内皮的分子途径。我们的目标是确定 MEF2(肌细胞增强因子 2)家族转录因子在促进抗动脉粥样硬化内皮中的作用。
在这里,我们通过内皮细胞特异性敲除内皮中的 3 种 MEF2 因子(Mef2a、-c 和 -d),表明 MEF2 是血管稳态的关键调节因子。MEF2 缺陷导致全身炎症、出血、血小板减少、白细胞增多和快速致死。转录组分析显示,MEF2 是正常调节 3 种途径所必需的,这 3 种途径决定了内皮对血流反应的能力。具体而言,MEF2 是表达 Klf2 和 Klf4 的必需条件,这 2 个部分冗余的因子对于促进抗炎和抗血栓形成的内皮至关重要。这种关键的需求导致内皮特异性缺失 和 之间存在表型相似性。此外,MEF2 调节 Notch 家族基因 Notch1、Dll1 和 Jag1 的表达,这些基因也促进抗动脉粥样硬化的内皮。与这些抗动脉粥样硬化途径相反,MEF2 缺陷通过增加 TAZ(具有 PDZ 结合基序的转录共激活因子)的数量而上调促进动脉粥样硬化形成的途径。
我们的结果表明,MEF2 是几个转录因子的关键上游调节剂,这些转录因子负责影响动脉粥样硬化发展和促进抗炎和抗血栓形成内皮的基因表达程序。